8/2/2010

Teva Pharmaceutical Industries announced that Canada's antitrust regulator cleared its takeover of Ratiopharm, a generic-drug firm in Germany, for almost $5 billion. The acquisition marks the Israeli drugmaker's second major deal within two years.

Related Summaries